Clinical Trial Update: A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis [Phase 2]

View source ↗

Summary

Phase IIa study evaluating intravenous rituximab in pediatric participants with granulomatosis with polyangiitis or microscopic polyangiitis has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Granulomatosis With Polyangiitis | Phase 2 | Status: COMPLETED | Results posted: 2019-06-26